Abiopharma

🔍 Jacobsen Frode (Executive)

Company: Opera Ltd (OPRA)

Report Date: 2026-06-17

Detailed Transactions and Holdings:

• Sold 25,600 shares of American Depositary Shares at $18.88 per share (Direct)
  Date: 2026-06-17 | Code: S | equity_swap_involved: false | shares_owned_after: 87,725.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 44,400 shares of American Depositary Shares at $18.52 per share (Direct)
  Date: 2026-06-18 | Code: S | equity_swap_involved: false | shares_owned_after: 43,325.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Each American Depositary Share ("ADS") represents one Ordinary Share of the Issuer.
• F2: The price reported in Column 4 for each transaction reflects the weighted average sale price. The shares sold on June 17, 2026 were sold in multiple transactions at prices ranging from $18.70 to $19.15 per share, inclusive. The shares sold on June 18, 2026 were sold in multiple transactions at prices ranging from $18.14 to $18.82 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• REMARKS: The Issuer is a foreign private issuer as defined under Rule 3b-4 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). In accordance with Rule 3a12-3(b) under the Exchange Act, the Reporting Person is exempt from the short-swing profit recovery provisions of Section 16(b) of the Exchange Act.